{"id":5003,"date":"2025-06-12T08:11:47","date_gmt":"2025-06-12T07:11:47","guid":{"rendered":"https:\/\/cbmeds.in\/?post_type=product&#038;p=5003"},"modified":"2025-06-12T08:18:13","modified_gmt":"2025-06-12T07:18:13","slug":"tazverik-200-mg-tazemetostat","status":"publish","type":"product","link":"https:\/\/cbmeds.in\/?product=tazverik-200-mg-tazemetostat","title":{"rendered":"TAZVERIK 200 MG (TAZEMETOSTAT)"},"content":{"rendered":"<h2 id=\"uses\" class=\"ddc-anchor-offset\">What is Tazverik?<\/h2>\n<p>&nbsp;<\/p>\n<p>Tazverik is used to treat adults and pediatric patients aged 16 years and older with advanced epithelioid sarcoma, a rare slow-growing type of soft tissue cancer. This medicine is used when the cancer has spread to other parts of the body (metastatic) or cannot be removed with surgery.<\/p>\n<p>Tazverik is also used to treat follicular lymphoma when the disease has come back or did not respond to treatment in adults:<\/p>\n<ul>\n<li>whose tumors have an abnormal EZH2 gene, and who have been treated with at least two prior medicines. Your healthcare provider will perform a test to make sure Tazverik is right for you.<\/li>\n<li>who have no other satisfactory treatment options.<\/li>\n<\/ul>\n<h2 data-start=\"151\" data-end=\"168\">\ud83c\udfe5 Indications<\/h2>\n<p>&nbsp;<\/p>\n<h3 data-start=\"169\" data-end=\"199\">1. <strong data-start=\"176\" data-end=\"199\">Epithelioid Sarcoma<\/strong><\/h3>\n<ul data-start=\"200\" data-end=\"404\">\n<li data-start=\"200\" data-end=\"239\">\n<p data-start=\"202\" data-end=\"239\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">FDA approved in January\u202f2020 for <strong data-start=\"33\" data-end=\"87\">metastatic or locally advanced epithelioid sarcoma<\/strong> not amenable to complete resection.<\/span><\/p>\n<\/li>\n<li data-start=\"240\" data-end=\"404\">\n<p data-start=\"242\" data-end=\"279\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Based on the phase\u202fII EZH\u2011202 trial with 62 patients (median age 34), showing:<\/span><\/p>\n<ul data-start=\"282\" data-end=\"404\">\n<li data-start=\"282\" data-end=\"323\">\n<p data-start=\"284\" data-end=\"323\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"11\" data-is-only-node=\"\">ORR 15%<\/strong> (1.6% CR, 13% PR)<\/span><\/p>\n<\/li>\n<li data-start=\"326\" data-end=\"404\">\n<p data-start=\"328\" data-end=\"404\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"21\" data-is-only-node=\"\">67% of responders<\/strong> maintained response \u22656 months<\/span><\/p>\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h3 data-start=\"406\" data-end=\"436\">2. <strong data-start=\"413\" data-end=\"436\">Follicular Lymphoma<\/strong><\/h3>\n<ul data-start=\"437\" data-end=\"515\">\n<li data-start=\"437\" data-end=\"515\">\n<p data-start=\"439\" data-end=\"515\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Approved for relapsed or refractory follicular lymphoma in patients aged \u2265\u202f16\u202fyears with <strong data-start=\"89\" data-end=\"107\">EZH2 mutations<\/strong> who have received \u22652 prior therapies<\/span><\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"517\" data-end=\"520\" \/>\n<h2 data-start=\"522\" data-end=\"551\">\ud83d\udc8a Dosage &amp; Administration<\/h2>\n<p>&nbsp;<\/p>\n<ul data-start=\"552\" data-end=\"717\">\n<li data-start=\"552\" data-end=\"634\">\n<p data-start=\"554\" data-end=\"634\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"29\" data-is-only-node=\"\">800\u202fmg orally twice daily<\/strong> (total 1600\u202fmg\/day), i.e., four 200\u202fmg tablets<\/span><\/p>\n<\/li>\n<li data-start=\"635\" data-end=\"717\">\n<p data-start=\"637\" data-end=\"717\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Can be taken <strong data-start=\"13\" data-end=\"37\">with or without food<\/strong>; tablets should be swallowed whole<\/span><\/p>\n<\/li>\n<\/ul>\n<p data-start=\"719\" data-end=\"752\"><strong data-start=\"719\" data-end=\"738\">Dose reductions<\/strong> for toxicity:<\/p>\n<ul data-start=\"753\" data-end=\"835\">\n<li data-start=\"753\" data-end=\"835\">\n<p data-start=\"755\" data-end=\"835\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Reduce to 600\u202fmg BID, then 400\u202fmg BID; discontinue if 400\u202fmg BID intolerance persists<\/span><\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"837\" data-end=\"840\" \/>\n<h2 data-start=\"842\" data-end=\"870\">\u26a0\ufe0f Warnings &amp; Precautions<\/h2>\n<p>&nbsp;<\/p>\n<ul data-start=\"871\" data-end=\"1292\">\n<li data-start=\"871\" data-end=\"953\">\n<p data-start=\"873\" data-end=\"953\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"26\" data-is-only-node=\"\">Secondary malignancies<\/strong>: Risk of MDS, AML (~0.6%), and T-cell lymphoblastic lymphoma. Long\u2011term follow-up is advised<\/span> .<\/p>\n<\/li>\n<li data-start=\"954\" data-end=\"1126\">\n<p data-start=\"956\" data-end=\"995\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"18\" data-is-only-node=\"\">Fetal toxicity<\/strong>: Pregnancy category &#8211; can cause fetal harm; requires non-hormonal contraception for:<\/span><\/p>\n<ul data-start=\"998\" data-end=\"1126\">\n<li data-start=\"998\" data-end=\"1041\">\n<p data-start=\"1000\" data-end=\"1041\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"9\" data-is-only-node=\"\">Women<\/strong>: during treatment and for 6 months after<\/span><\/p>\n<\/li>\n<li data-start=\"1044\" data-end=\"1126\">\n<p data-start=\"1046\" data-end=\"1126\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"7\" data-is-only-node=\"\">Men<\/strong>: for 3 months after final dose<\/span> .<\/p>\n<\/li>\n<\/ul>\n<\/li>\n<li data-start=\"1127\" data-end=\"1209\">\n<p data-start=\"1129\" data-end=\"1209\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"21\" data-is-only-node=\"\">Drug Interactions<\/strong>: Avoid strong\/moderate CYP3A4 inhibitors\/inducers; hormonal contraceptives may be less effective<\/span> .<\/p>\n<\/li>\n<li data-start=\"1210\" data-end=\"1292\">\n<p data-start=\"1212\" data-end=\"1292\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"28\" data-is-only-node=\"\">Hepatic\/Renal impairment<\/strong>: No adjustment needed for mild-severe renal disease; not studied in moderate-severe hepatic impairment<\/span><\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"1294\" data-end=\"1297\" \/>\n<h2 data-start=\"1299\" data-end=\"1317\">\u2695\ufe0f Side Effects<\/h2>\n<p>&nbsp;<\/p>\n<p data-start=\"1318\" data-end=\"1364\"><strong data-start=\"1318\" data-end=\"1340\">Very common (\u226520%)<\/strong> in epithelioid sarcoma:<\/p>\n<ul data-start=\"1365\" data-end=\"1447\">\n<li data-start=\"1365\" data-end=\"1447\">\n<p data-start=\"1367\" data-end=\"1447\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Pain (52%), fatigue (47%), nausea (36%), decreased appetite (26%), vomiting (24%), constipation (21%)<\/span><\/p>\n<\/li>\n<\/ul>\n<p data-start=\"1449\" data-end=\"1471\"><strong data-start=\"1449\" data-end=\"1464\">Serious AEs<\/strong> (\u22653%):<\/p>\n<ul data-start=\"1472\" data-end=\"1554\">\n<li data-start=\"1472\" data-end=\"1554\">\n<p data-start=\"1474\" data-end=\"1554\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Hemorrhage, pleural effusion, skin infections, dyspnea, and respiratory distress; 37% experienced serious AEs, with one permanent discontinuation due to altered mood<\/span><\/p>\n<\/li>\n<\/ul>\n<p data-start=\"1556\" data-end=\"1595\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Additional patient counseling:<\/span><\/p>\n<ul data-start=\"1596\" data-end=\"1678\">\n<li data-start=\"1596\" data-end=\"1678\">\n<p data-start=\"1598\" data-end=\"1678\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\">Watch for signs of bleeding, bruising, infections, fatigue, and respiratory issues<\/span> .<\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"1680\" data-end=\"1683\" \/>\n<h2 data-start=\"1685\" data-end=\"1710\">\ud83d\udcdd Practical Use Notes<\/h2>\n<p>&nbsp;<\/p>\n<ul data-start=\"1711\" data-end=\"1970\">\n<li data-start=\"1711\" data-end=\"1793\">\n<p data-start=\"1713\" data-end=\"1793\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"18\" data-is-only-node=\"\">Administration<\/strong>: Take consistently at the same times daily; if vomiting occurs post-dose, skip and continue schedule<\/span><\/p>\n<\/li>\n<li data-start=\"1794\" data-end=\"1876\">\n<p data-start=\"1796\" data-end=\"1876\"><span class=\"relative -mx-px my-[-0.2rem] rounded px-px py-[0.2rem] transition-colors duration-100 ease-in-out\"><strong data-start=\"0\" data-end=\"8\" data-is-only-node=\"\">Diet<\/strong>: Avoid grapefruit and St John&#8217;s wort<\/span><\/p>\n<\/li>\n<li data-start=\"1877\" data-end=\"1970\">\n<p data-start=\"1879\" data-end=\"1970\"><strong data-start=\"1879\" data-end=\"1893\">Monitoring<\/strong>: Periodic CBC, LFTs, infection surveillance, and secondary cancer screening.<\/p>\n<\/li>\n<\/ul>\n<hr data-start=\"1972\" data-end=\"1975\" \/>\n<h2 data-start=\"1977\" data-end=\"1992\">\u2705 Conclusion<\/h2>\n<p>&nbsp;<\/p>\n<p data-start=\"1993\" data-end=\"2383\">Tazverik (tazemetostat) offers a targeted oral option for two rare, EZH2-driven cancers: epithelioid sarcoma and follicular lymphoma. It provides durable responses for some patients, though risks include secondary malignancies, AEs like fatigue and GI symptoms, and significant drug interactions. Proper dose adjustments, contraception, and long-term monitoring are essential for safe use.<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p><strong data-start=\"39\" data-end=\"53\">Brand Name <\/strong>: <strong data-start=\"55\" data-end=\"68\">Tazverik<\/strong><br data-start=\"68\" data-end=\"71\" \/><strong data-start=\"71\" data-end=\"92\">Salt\/Generic Name <\/strong>: <strong data-start=\"94\" data-end=\"125\">Tazemetostat (hydrobromide)<\/strong><br data-start=\"125\" data-end=\"128\" data-is-only-node=\"\" \/><strong data-start=\"128\" data-end=\"144\">Manufacturer <\/strong>: <strong data-start=\"146\" data-end=\"163\">Epizyme, Inc.<\/strong> globally\u00a0<br data-start=\"218\" data-end=\"221\" \/><strong data-start=\"221\" data-end=\"247\">Formulation &amp; Strength <\/strong>: Oral film\u2011coated tablets, <strong data-start=\"275\" data-end=\"285\">200\u202fmg<\/strong><br data-start=\"285\" data-end=\"288\" \/><strong data-start=\"288\" data-end=\"303\">Indications <\/strong>: Treatment of <strong data-start=\"318\" data-end=\"384\">relapsed\/refractory EZH2\u2011mutation-positive follicular lymphoma<\/strong> and <strong data-start=\"389\" data-end=\"443\">metastatic or locally advanced epithelioid sarcoma<\/strong> in adults and adolescents \u226516 years<\/p>\n","protected":false},"featured_media":5004,"comment_status":"open","ping_status":"closed","template":"","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"set","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}}},"product_brand":[],"product_cat":[33],"product_tag":[],"class_list":{"0":"post-5003","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-lymphoma","7":"desktop-align-left","8":"tablet-align-left","9":"mobile-align-left","11":"first","12":"instock","13":"shipping-taxable","14":"product-type-simple"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TAZVERIK 200 MG (TAZEMETOSTAT) - Curiance Biotech<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cbmeds.in\/?product=tazverik-200-mg-tazemetostat\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TAZVERIK 200 MG (TAZEMETOSTAT) - Curiance Biotech\" \/>\n<meta property=\"og:description\" content=\"Brand Name : TazverikSalt\/Generic Name : Tazemetostat (hydrobromide)Manufacturer : Epizyme, Inc. globally\u00a0Formulation &amp; Strength : Oral film\u2011coated tablets, 200\u202fmgIndications : Treatment of relapsed\/refractory EZH2\u2011mutation-positive follicular lymphoma and metastatic or locally advanced epithelioid sarcoma in adults and adolescents \u226516 years\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cbmeds.in\/?product=tazverik-200-mg-tazemetostat\" \/>\n<meta property=\"og:site_name\" content=\"Curiance Biotech\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-12T07:18:13+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/cbmeds.in\/wp-content\/uploads\/2025\/06\/TAZVERIK.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"473\" \/>\n\t<meta property=\"og:image:height\" content=\"624\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?product=tazverik-200-mg-tazemetostat\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/?product=tazverik-200-mg-tazemetostat\",\"name\":\"TAZVERIK 200 MG (TAZEMETOSTAT) - Curiance Biotech\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?product=tazverik-200-mg-tazemetostat#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?product=tazverik-200-mg-tazemetostat#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/TAZVERIK.jpg\",\"datePublished\":\"2025-06-12T07:11:47+00:00\",\"dateModified\":\"2025-06-12T07:18:13+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?product=tazverik-200-mg-tazemetostat#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/cbmeds.in\\\/?product=tazverik-200-mg-tazemetostat\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?product=tazverik-200-mg-tazemetostat#primaryimage\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/TAZVERIK.jpg\",\"contentUrl\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/TAZVERIK.jpg\",\"width\":473,\"height\":624},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/?product=tazverik-200-mg-tazemetostat#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/cbmeds.in\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop\",\"item\":\"https:\\\/\\\/cbmeds.in\\\/?page_id=13\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"TAZVERIK 200 MG (TAZEMETOSTAT)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#website\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/\",\"name\":\"cbmeds.in\",\"description\":\"Tomorrow&#039;s Medicine Today\",\"publisher\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#organization\"},\"alternateName\":\"Curiance Biotech\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/cbmeds.in\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#organization\",\"name\":\"CB Meds\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Logo-1-1-1.png\",\"contentUrl\":\"https:\\\/\\\/cbmeds.in\\\/wp-content\\\/uploads\\\/2023\\\/09\\\/Logo-1-1-1.png\",\"width\":640,\"height\":640,\"caption\":\"CB Meds\"},\"image\":{\"@id\":\"https:\\\/\\\/cbmeds.in\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TAZVERIK 200 MG (TAZEMETOSTAT) - Curiance Biotech","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cbmeds.in\/?product=tazverik-200-mg-tazemetostat","og_locale":"en_US","og_type":"article","og_title":"TAZVERIK 200 MG (TAZEMETOSTAT) - Curiance Biotech","og_description":"Brand Name : TazverikSalt\/Generic Name : Tazemetostat (hydrobromide)Manufacturer : Epizyme, Inc. globally\u00a0Formulation &amp; Strength : Oral film\u2011coated tablets, 200\u202fmgIndications : Treatment of relapsed\/refractory EZH2\u2011mutation-positive follicular lymphoma and metastatic or locally advanced epithelioid sarcoma in adults and adolescents \u226516 years","og_url":"https:\/\/cbmeds.in\/?product=tazverik-200-mg-tazemetostat","og_site_name":"Curiance Biotech","article_modified_time":"2025-06-12T07:18:13+00:00","og_image":[{"width":473,"height":624,"url":"http:\/\/cbmeds.in\/wp-content\/uploads\/2025\/06\/TAZVERIK.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/cbmeds.in\/?product=tazverik-200-mg-tazemetostat","url":"https:\/\/cbmeds.in\/?product=tazverik-200-mg-tazemetostat","name":"TAZVERIK 200 MG (TAZEMETOSTAT) - Curiance Biotech","isPartOf":{"@id":"https:\/\/cbmeds.in\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cbmeds.in\/?product=tazverik-200-mg-tazemetostat#primaryimage"},"image":{"@id":"https:\/\/cbmeds.in\/?product=tazverik-200-mg-tazemetostat#primaryimage"},"thumbnailUrl":"https:\/\/cbmeds.in\/wp-content\/uploads\/2025\/06\/TAZVERIK.jpg","datePublished":"2025-06-12T07:11:47+00:00","dateModified":"2025-06-12T07:18:13+00:00","breadcrumb":{"@id":"https:\/\/cbmeds.in\/?product=tazverik-200-mg-tazemetostat#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cbmeds.in\/?product=tazverik-200-mg-tazemetostat"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cbmeds.in\/?product=tazverik-200-mg-tazemetostat#primaryimage","url":"https:\/\/cbmeds.in\/wp-content\/uploads\/2025\/06\/TAZVERIK.jpg","contentUrl":"https:\/\/cbmeds.in\/wp-content\/uploads\/2025\/06\/TAZVERIK.jpg","width":473,"height":624},{"@type":"BreadcrumbList","@id":"https:\/\/cbmeds.in\/?product=tazverik-200-mg-tazemetostat#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cbmeds.in\/"},{"@type":"ListItem","position":2,"name":"Shop","item":"https:\/\/cbmeds.in\/?page_id=13"},{"@type":"ListItem","position":3,"name":"TAZVERIK 200 MG (TAZEMETOSTAT)"}]},{"@type":"WebSite","@id":"https:\/\/cbmeds.in\/#website","url":"https:\/\/cbmeds.in\/","name":"cbmeds.in","description":"Tomorrow&#039;s Medicine Today","publisher":{"@id":"https:\/\/cbmeds.in\/#organization"},"alternateName":"Curiance Biotech","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cbmeds.in\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cbmeds.in\/#organization","name":"CB Meds","url":"https:\/\/cbmeds.in\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cbmeds.in\/#\/schema\/logo\/image\/","url":"https:\/\/cbmeds.in\/wp-content\/uploads\/2023\/09\/Logo-1-1-1.png","contentUrl":"https:\/\/cbmeds.in\/wp-content\/uploads\/2023\/09\/Logo-1-1-1.png","width":640,"height":640,"caption":"CB Meds"},"image":{"@id":"https:\/\/cbmeds.in\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/product\/5003","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/product"}],"about":[{"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=5003"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=\/wp\/v2\/media\/5004"}],"wp:attachment":[{"href":"https:\/\/cbmeds.in\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=5003"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_brand&post=5003"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_cat&post=5003"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/cbmeds.in\/index.php?rest_route=%2Fwp%2Fv2%2Fproduct_tag&post=5003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}